Induction of apoptosis by lysophosphatidic acid acyltransferase (LPAAT)-β inhibitors in multiple myeloma (MM).

被引:0
|
作者
Hideshima, T
Hayashi, T
Akiyama, M
Chauhan, D
Richardson, PG
Mitsiades, C
Mitsiades, N
Munshi, NC
Singer, JW
Anderson, KC
机构
[1] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
[2] Cell Therapeut Inc, Seattle, WA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3213
引用
收藏
页码:813A / 813A
页数:1
相关论文
共 50 条
  • [1] Anti-tumor activity of lysophosphatidic acid acyltransferase (LPAAT)-β inhibitors in multiple myeloma (MM).
    Hideshima, T
    Chauhan, D
    Hayashi, T
    Podar, K
    Akiyama, M
    Mitsiades, C
    Mitsiades, N
    Gong, BQ
    Bonham, L
    de Vries, P
    Munshi, NC
    Richardson, PG
    Singer, JW
    Anderson, KC
    BLOOD, 2003, 102 (11) : 451A - 452A
  • [2] Lysophosphatidic acid acyltransferase-β (LPAAT-β):: A new target for selective induction of apoptosis in tumor cells;: an overview
    Singer, JW
    Bonham, L
    de Vries, P
    Leung, D
    Coon, M
    Ball, A
    McCormick, R
    Hollenback, D
    Tulinsky, J
    White, T
    BLOOD, 2002, 100 (11) : 217B - 217B
  • [3] Molecular evolution of the lysophosphatidic acid acyltransferase (LPAAT) gene family
    Koerbes, Ana Paula
    Kulcheski, Franceli Rodrigues
    Margis, Rogerio
    Margis-Pinheiro, Marcia
    Turchetto-Zolet, Andreia Carina
    MOLECULAR PHYLOGENETICS AND EVOLUTION, 2016, 96 : 55 - 69
  • [4] Lysophosphatidic Acid Acyltransferase β (LPAATβ) Promotes the Tumor Growth of Human Osteosarcoma
    Rastegar, Farbod
    Gao, Jian-Li
    Shenaq, Deana
    Luo, Qing
    Shi, Qiong
    Kim, Stephanie H.
    Jiang, Wei
    Wagner, Eric R.
    Huang, Enyi
    Gao, Yanhong
    Shen, Jikun
    Yang, Ke
    He, Bai-Cheng
    Chen, Liang
    Zuo, Guo-Wei
    Luo, Jinyong
    Luo, Xiaoji
    Bi, Yang
    Liu, Xing
    Li, Mi
    Hu, Ning
    Wang, Linyuan
    Luther, Gaurav
    Luu, Hue H.
    Haydon, Rex C.
    He, Tong-Chuan
    PLOS ONE, 2010, 5 (12):
  • [5] Antitumor activity of lysophosphatidic acid acyltransferase-β inhibitors, a novel class of agents, in multiple myeloma
    Hideshima, T
    Chauhan, D
    Hayashi, T
    Podar, K
    Akiyama, M
    Mitsiades, C
    MItsiades, N
    Gong, BQ
    Bonham, L
    de Vries, P
    Munshi, N
    Richardson, PG
    Singer, JW
    Anderson, KC
    CANCER RESEARCH, 2003, 63 (23) : 8428 - 8436
  • [7] The Structure and Function of Acylglycerophosphate Acyltransferase 4/Lysophosphatidic Acid Acyltransferase Delta (AGPAT4/LPAATδ)
    Zhukovsky, Mikhail A.
    Filograna, Angela
    Luini, Alberto
    Corda, Daniela
    Valente, Carmen
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019, 7
  • [8] Induction of apoptosis using inhibitors of lysophosphatidic acid acyltransferase-β (LPAAT-β) and anti-CD20 monoclonal antibodies in the treatment of human non-Hodgkin's lymphomas.
    Pagel, JM
    Laugen, C
    Ball, A
    Coon, M
    deVries, P
    Bonham, L
    Singer, J
    Press, OW
    BLOOD, 2003, 102 (11) : 69A - 70A
  • [9] Lysophosphatidic acid acyltransferase-β:: a novel target for induction of tumour cell apoptosis
    Bonham, L
    Leung, DW
    White, T
    Hollenback, D
    Klein, P
    Tulinsky, J
    Coon, M
    de Vries, P
    Singer, JW
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2003, 7 (05) : 643 - 661
  • [10] Molecular characterization of PS-341 (bortezomib) resistance: implications for overcoming resistance using lysophosphatidic acid acyltransferase (LPAAT)-β inhibitors
    Teru Hideshima
    Dharminder Chauhan
    Kenji Ishitsuka
    Hiroshi Yasui
    Noopur Raje
    Shaji Kumar
    Klaus Podar
    Constantine Mitsiades
    Hiromasa Hideshima
    Lynn Bonham
    Nikhil C Munshi
    Paul G Richardson
    Jack W Singer
    Kenneth C Anderson
    Oncogene, 2005, 24 : 3121 - 3129